Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-07

FDA Approved: PIOGLITAZONE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Pioglitazone submitted by NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

SUPPL AP for PIOGLITAZONE (PIOGLITAZONE)